Collegium Pharmaceutical lowered its 2026 revenue and EBITDA guidance due to challenges but remains a high-risk buy as the market may be overly pessimistic. Its ADHD drugs Jornay PM and AZSTARYS, which make up over 30% of expected 2026 sales, are growing strongly and have patent protection into the 2030s. The decline in its pain drug franchise is gradual, with some products facing patent or generic competition risks. At a valuation of about 2.9 times 2026 owner earnings and an estimated fair value of $35 per share, the stock offers significant upside despite legal and operational risks.
Collegium Pharmaceutical's recent guidance cut offers context for readers tracking health-sector stocks. For readers following health-sector US stocks on Pluang, here is the market snapshot as of Oct 17, 2026 23:31 WIB: out of 150 priced stocks, 29 rose and 118 fell. Notable movers include ImmunityBio Inc. (IBRX) at USD 9.18 with a 1-day change of -8.20%, Twist Bioscience Corp (TWST) at USD 132.75 down 8.13% with Pluang order activity showing 63% Sell and 37% Buy, and Moderna, Inc. (MRNA) at USD 218.01 down 7.82% with a typical hold time on Pluang of 58 days and order activity nearly balanced at 51% Sell / 49% Buy.
Chery Auto will showcase its purpose-built Level 4 (L4) Robotaxi at the 2026 Chery International User Summit and sign a strategic cooperation agreement with UAE-based K2. The Robotaxi offers a fully driverless passenger experience from booking to rid...
AiMOGA Robotics, a Chery brand, unveiled Mobo, its first consumer-grade humanoid robot designed for home companionship, at the 2026 Chery International User Summit. Powered by AiMOGA's proprietary AI system MoAgent, Mobo can interpret complex command...
AiMOGA Robotics, a Chery brand, unveiled Mobo, its first consumer humanoid robot designed for home companionship, at the 2026 Chery International User Summit. Mobo uses advanced AI to understand complex commands, navigate home environments, and remem...
AiMOGA Robotics, a brand under Chery, introduced Mobo, its first consumer-grade humanoid robot designed as a family companion, at the 2026 Chery International User Summit. Mobo operates with AiMOGA's proprietary MoAgent AI, enabling it to understand ...
AiMOGA Robotics, a Chery brand, will debut Mobo, its first consumer-grade humanoid robot designed as a home companion, at the 2026 Chery International User Summit in Wuhu, China. Mobo features advanced AI for understanding complex commands, spatial a...
